194 related articles for article (PubMed ID: 20331862)
1. A rational use of glucocorticoids in patients with early arthritis has a minimal impact on bone mass.
Ibañez M; Ortiz AM; Castrejón I; García-Vadillo JA; Carvajal I; Castañeda S; González-Alvaro I
Arthritis Res Ther; 2010; 12(2):R50. PubMed ID: 20331862
[TBL] [Abstract][Full Text] [Related]
2. Are changes in bone mineral density different between groups of early rheumatoid arthritis patients treated according to a tight control strategy with or without prednisone if osteoporosis prophylaxis is applied?
van der Goes MC; Jacobs JW; Jurgens MS; Bakker MF; van der Veen MJ; van der Werf JH; Welsing PM; Bijlsma JW
Osteoporos Int; 2013 Apr; 24(4):1429-36. PubMed ID: 23011680
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of body composition and bone mineral density in women with rheumatoid arthritis].
Silva RG; Pippa MG; Zerbin CA
Rev Assoc Med Bras (1992); 2007; 53(2):135-41. PubMed ID: 17568917
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of tumor necrosis factor inhibitors and glucocorticoids on bone density in rheumatoid arthritis and ankylosing spondylitis trials.
Siu S; Haraoui B; Bissonnette R; Bessette L; Roubille C; Richer V; Starnino T; McCourt C; McFarlane A; Fleming P; Kraft J; Lynde C; Gulliver W; Keeling S; Dutz J; Pope JE
Arthritis Care Res (Hoboken); 2015 May; 67(6):754-64. PubMed ID: 25418272
[TBL] [Abstract][Full Text] [Related]
5. Disease activity and disability but probably not glucocorticoid treatment predicts loss in bone mineral density in women with early rheumatoid arthritis.
Book C; Karlsson M; Akesson K; Jacobsson L
Scand J Rheumatol; 2008; 37(4):248-54. PubMed ID: 18612924
[TBL] [Abstract][Full Text] [Related]
6. Use of bisphosphonate might be important to improve bone mineral density in patients with rheumatoid arthritis even under tight control: the TOMORROW study.
Tada M; Inui K; Sugioka Y; Mamoto K; Okano T; Anno S; Koike T
Rheumatol Int; 2017 Jun; 37(6):999-1005. PubMed ID: 28405825
[TBL] [Abstract][Full Text] [Related]
7. Does low-dose and short-term glucocorticoids treatment increase the risk of osteoporosis in rheumatoid arthritis female patients?
Korczowska I; Olewicz-Gawlik A; Trefler J; Hrycaj P; Krzysztof Łacki J
Clin Rheumatol; 2008 May; 27(5):565-72. PubMed ID: 17909741
[TBL] [Abstract][Full Text] [Related]
8. Changes in bone mineral density following discontinuation or continuation of alendronate therapy in glucocorticoid-treated patients: a retrospective, observational study.
Emkey R; Delmas PD; Goemaere S; Liberman UA; Poubelle PE; Daifotis AG; Verbruggen N; Lombardi A; Czachur M
Arthritis Rheum; 2003 Apr; 48(4):1102-8. PubMed ID: 12687554
[TBL] [Abstract][Full Text] [Related]
9. Are glucocorticoids harmful to bone in early rheumatoid arthritis?
Lems WF
Ann N Y Acad Sci; 2014 May; 1318():50-4. PubMed ID: 24739059
[TBL] [Abstract][Full Text] [Related]
10. The relationship between focal erosions and generalized osteoporosis in postmenopausal women with rheumatoid arthritis.
Solomon DH; Finkelstein JS; Shadick N; LeBoff MS; Winalski CS; Stedman M; Glass R; Brookhart MA; Weinblatt ME; Gravallese EM
Arthritis Rheum; 2009 Jun; 60(6):1624-31. PubMed ID: 19479876
[TBL] [Abstract][Full Text] [Related]
11. Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss.
Wijbrandts CA; Klaasen R; Dijkgraaf MG; Gerlag DM; van Eck-Smit BL; Tak PP
Ann Rheum Dis; 2009 Mar; 68(3):373-6. PubMed ID: 18408246
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and risk factors associated with glucocorticoid-induced osteoporosis in Chinese patients with rheumatoid arthritis.
Ma CC; Xu SQ; Gong X; Wu Y; Qi S; Liu W; Xu JH
Arch Osteoporos; 2017 Dec; 12(1):33. PubMed ID: 28374332
[TBL] [Abstract][Full Text] [Related]
13. Comparison of peripheral quantitative computed tomography forearm bone density versus DXA in rheumatoid arthritis patients and controls.
Juhász B; Gulyás K; Horváth Á; Pethő Z; Bhattoa HP; Váncsa A; Szekanecz É; Horváth C; Kocsis J; Horváth Z; Hodosi K; Szántó S; Szűcs G; Szekanecz Z
Osteoporos Int; 2017 Apr; 28(4):1271-1277. PubMed ID: 27942777
[TBL] [Abstract][Full Text] [Related]
14. Sex and age do not modify the association between glucocorticoids and bone mineral density in patients with rheumatoid arthritis: a cross-sectional study.
Palmowski A; Boyadzhieva Z; Nielsen SM; Muche B; Hermann S; Boers M; Bliddal H; Christensen R; Wiebe E; Buttgereit F
Arthritis Res Ther; 2023 Jun; 25(1):98. PubMed ID: 37287080
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing spinal sagittal balance, bone mineral density, and Oswestry Disability Index outcome measures in patients with rheumatoid arthritis.
Masamoto K; Otsuki B; Fujibayashi S; Shima K; Ito H; Furu M; Hashimoto M; Tanaka M; Lyman S; Yoshitomi H; Tanida S; Mimori T; Matsuda S
Eur Spine J; 2018 Feb; 27(2):406-415. PubMed ID: 29185111
[TBL] [Abstract][Full Text] [Related]
16. Changes in hand and generalised bone mineral density in patients with recent-onset rheumatoid arthritis.
Güler-Yüksel M; Allaart CF; Goekoop-Ruiterman YP; de Vries-Bouwstra JK; van Groenendael JH; Mallée C; de Bois MH; Breedveld FC; Dijkmans BA; Lems WF
Ann Rheum Dis; 2009 Mar; 68(3):330-6. PubMed ID: 18375540
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of bone mineral density in patients with rheumatoid arthritis. Influence of disease activity and glucocorticoid therapy.
Cortet B; Flipo RM; Blanckaert F; Duquesnoy B; Marchandise X; Delcambre B
Rev Rhum Engl Ed; 1997; 64(7-9):451-8. PubMed ID: 9338926
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis.
Vis M; Havaardsholm EA; Haugeberg G; Uhlig T; Voskuyl AE; van de Stadt RJ; Dijkmans BA; Woolf AD; Kvien TK; Lems WF
Ann Rheum Dis; 2006 Nov; 65(11):1495-9. PubMed ID: 16606653
[TBL] [Abstract][Full Text] [Related]
19. Periarticular osteoporosis of the forearm correlated with joint destruction and functional impairment in patients with rheumatoid arthritis.
Iwata T; Ito H; Furu M; Hashimoto M; Fujii T; Ishikawa M; Yamakawa N; Terao C; Azukizawa M; Hamamoto Y; Mimori T; Akiyama H; Matsuda S
Osteoporos Int; 2016 Feb; 27(2):691-701. PubMed ID: 26243360
[TBL] [Abstract][Full Text] [Related]
20. Low-dose glucocorticoids in early rheumatoid arthritis: discordant effects on bone mineral density and fractures?
van Everdingen AA; Siewertsz van Reesema DR; Jacobs JW; Bijlsma JW
Clin Exp Rheumatol; 2003; 21(2):155-60. PubMed ID: 12747268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
